President Donald Trump said his administration is pressuring pharmaceutical companies to break up childhood vaccines into ...

GLP-1 drugs, including Wegovy, Zepbound, and Foundayo, help patients lose weight by mimicking a hormone that makes the body ...

Vera Therapeutics, Inc. ( VERA) reported that in the pivotal ORIGIN 3 trial of TRUTAKNA (atacicept-vymj), an FDA-approved dual BAFF and APRIL inhibitor, it stabilised kidney function and prevented ...

The latest installment in BioPharma Dive’s new visualization-focused series features a stock sell-off that confused Wall ...

Tempus AI (NASDAQ:TEM | TEM Price Prediction) is having a breakout week after Morgan Stanley remarks on September 15 ...

Shinhan Securities says Olix could become big pharma's only ALK7 obesity drug licensing candidate as rivals report first ...

Prime Minister Kretschmer spoke out clearly in the state parliament regarding the pharmaceutical company GSK's plans to close ...

Berenberg Bank analyst Kerry Holford reiterated a Hold rating on GlaxoSmithKline today and set a price target of p2,200.00. According to TipRanks, Holford is a 4-star analyst with an average return of ...

The Department of Health recommends that regional flu vaccination campaigns be launched from the start of October ...

Diageo agreed in June 2024 to sell its majority stake in Guinness Nigeria to the Tolaram group, a deal that closed the ...

GSK will acquire a trispecific T cell engager for multiple myeloma from Chimagen Biosciences in a deal worth up to $750 ...

AstraZeneca received a Hold rating and an £117.00 price target from Deutsche Bank analyst Emmanuel Papadakis today. Papadakis covers the Healthcare sector, focusing on stocks such as AstraZeneca, ...